Biotech Company Sanaria To Open New Malaria Vaccine Plant

by Medindia Content Team on  October 24, 2007 at 8:22 PM Drug News   - G J E 4
Biotech Company Sanaria To Open New Malaria Vaccine Plant
Biotechnology company Sanaria in Rockville, Md., plans to open a new malaria vaccine plant that was funded partially by a $29.3 million grant from the Bill & Melinda Gates Foundation and $3.5 million in federal small business grants, Gazette.Net reports.

Sanaria, which has been building the plant over the past six months, in 2006 began producing a malaria vaccine in conjunction with the PATH Malaria Vaccine Initiative. The vaccine is distinct because it was developed through the exposure of the Plasmodium falciparum parasite to radiation.

NIH earlier this year awarded Sanaria two grants that were allocated toward Phase I and II clinical trials. The Phase I grant will help the company find ways to preserve the vaccine. The Phase II grant will go toward developing different strains of the parasite that can help determine the vaccine's effectiveness.

Sanaria CEO Stephen Hoffman said he expects the vaccine to be 90% effective. The plant opening is a significant step in the effort to translate Sanaria's research into a "safe, highly efficacious vaccine," according to MVI Director Christian Loucq.

Source: Kaiser Family Foundation

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Sir, i am a research scholar and projact on malaria vaccination. pls give me information about malaria antigen.
guest Thursday, January 8, 2009
Sanaria continues to appear in the news, On Thursday May 15, 2008 Sanaria Inc. was named Emerging Company of the Year at the annual Technology Council of Maryland's Tech Awards Celebration honoring the state's technology leaders and rganizations. the members of the Sanaria team go to work every day with only one goal in mind, to develop a vaccine that will prevent
millions of deaths from malaria," said Sanaria founder and CEO, Stephen L. Hoffman. "I am honored to accept this award on their
behalf, and on behalf of our partners who have invested so much in us."

guest Tuesday, May 20, 2008
These working ladies are not able to look after their children. So without brain, they supports these such a stupid western things.
guest Wednesday, October 24, 2007

You May Also Like